Dennis Mulroy

Insider Reports History

Entity
Individual
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dennis Mulroy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ANAPTYSBIO, INC CHIEF FINANCIAL OFFICER Restricted Stock Unit 15.7K $343K $21.81 Jan 6, 2024 Direct
ANAPTYSBIO, INC CHIEF FINANCIAL OFFICER Common Stock 4.74K $190K $40.13 Sep 16, 2024 Direct
ANAPTYSBIO, INC CHIEF FINANCIAL OFFICER Stock Option (right to buy) 90.8K Jan 3, 2024 Direct
ANAPTYSBIO, INC CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 80.6K Sep 16, 2024 Direct
ANAPTYSBIO, INC CHIEF FINANCIAL OFFICER Restricted Stock Unit 0 Sep 14, 2024 Direct

Insider Reports Filed by Dennis Mulroy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANAB ANAPTYSBIO, INC Sep 14, 2024 6 -$286K 4 Sep 17, 2024 CHIEF FINANCIAL OFFICER
ANAB ANAPTYSBIO, INC Jul 22, 2024 1 $0 4 Jul 24, 2024 CHIEF FINANCIAL OFFICER
ANAB ANAPTYSBIO, INC May 22, 2024 1 -$35.6K 4 May 24, 2024 CHIEF FINANCIAL OFFICER
ANAB ANAPTYSBIO, INC Jan 30, 2024 1 -$72.4K 4 Feb 1, 2024 CHIEF FINANCIAL OFFICER
ANAB ANAPTYSBIO, INC Jan 6, 2024 3 -$47.5K 4 Jan 9, 2024 Chief Financial Officer
ANAB ANAPTYSBIO, INC Jan 3, 2024 2 $0 4 Jan 5, 2024 Chief Financial Officer
ANAB ANAPTYSBIO, INC Sep 14, 2023 4 -$116K 4 Sep 18, 2023 Chief Financial Officer
ANAB ANAPTYSBIO, INC Jan 6, 2023 2 $0 4 Jan 10, 2023 Chief Financial Officer
ANAB ANAPTYSBIO, INC Sep 14, 2022 1 $0 4 Sep 16, 2022 Chief Financial Officer
ANAB ANAPTYSBIO, INC Jun 23, 2022 1 $0 4 Jun 27, 2022 Chief Financial Officer
ANAB ANAPTYSBIO, INC Feb 10, 2022 1 $0 4 Feb 14, 2022 Chief Financial Officer
ANAB ANAPTYSBIO, INC Nov 15, 2021 1 $21.2K 4 Nov 17, 2021 Chief Financial Officer